Home  |  Contact

UniProtKB/Swiss-Prot P01160: Variant p.Arg150Gln

Natriuretic peptides A
Gene: NPPA
Variant information

Variant position:  150
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:  LP/P [Disclaimer]
The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change:  From Arginine (R) to Glutamine (Q) at position 150 (R150Q, p.Arg150Gln).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:  Change from large size and basic (R) to medium size and polar (Q)
The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:  1
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description:  In ATRST2.
Any additional useful information about the variant.

Other resources:  
Links to websites of interest for the variant.

Sequence information

Variant position:  150
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:  151
The length of the canonical sequence.

Location on the sequence:   CFGGRMDRIGAQSGLGCNSF  R Y
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation: 
The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         CFGGRMDRIGAQSGLGCNSFRY--


Mouse                         CFGGRIDRIGAQSGLGCNSFRY

Rat                           CFGGRIDRIGAQSGLGCNSFRY

Pig                           CFGGRMDRIGAQSGLGCNSFRY

Bovine                        CFGGRMDRIGAQSGLGCNSFRY

Rabbit                        CFGGRIDRIGAQSGLGCNSFRY

Sheep                         CFGGRMDRIGAQSGLGCNSFRY

Cat                           CFGGRMDRIGAQSGLGCNSFRY

Horse                         CFGGRMDRIGAQSGLGCNSFRY

Chicken                       CFGRRIDRIGSLSGMGCNGSRK

Sequence annotation in neighborhood:  
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.

Chain 26 – 151 Natriuretic peptides A
Peptide 119 – 151 Auriculin-C
Peptide 120 – 151 Urodilatin
Peptide 124 – 151 Atrial natriuretic peptide
Peptide 127 – 151 Auriculin-B
Peptide 127 – 150 Auriculin-A
Peptide 128 – 151 Atriopeptin-3
Peptide 128 – 150 Atriopeptin-2
Region 147 – 151 Important for degradation of atrial natriuretic peptide by IDE
Mutagenesis 147 – 151 Missing. Reduced degradation of atrial natriuretic peptide by IDE; when associated with S-124--126-R DEL.

Literature citations

Autosomal recessive atrial dilated cardiomyopathy with standstill evolution associated with mutation of natriuretic peptide precursor A.
Disertori M.; Quintarelli S.; Grasso M.; Pilotto A.; Narula N.; Favalli V.; Canclini C.; Diegoli M.; Mazzola S.; Marini M.; Del Greco M.; Bonmassari R.; Mase M.; Ravelli F.; Specchia C.; Arbustini E.;
Circ. Cardiovasc. Genet. 6:27-36(2013)

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.